Business Wire

Airship Journeys Powers Massive Conversion Gains for Brands Across the Globe

29.10.2020 11:30:00 EET | Business Wire | Press release

Share

Customer engagement company Airship today detailed the amazing success three brand marketers have achieved using Airship Journeys to more quickly and easily improve the business impact of cross-channel customer journeys. The customer journeys these marketers have optimized have driven double- and even triple-digit percentage performance improvements over baselines established by control groups.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201029005340/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Airship Journeys enables an at-a-glance understanding of how cross-channel journeys are performing against business goals, trending performance lifts against control group baselines to direct optimization efforts and maximize business value. (Graphic: Business Wire)

Airship Journeys combines everything marketers need to create, evaluate, test and optimize cross-channel customer engagement journeys in a single, intuitive visual UI. Only Airship Journeys allows marketers to zoom in from glanceable, color-coded visualizations of journey performance against business goals and baselines, to view and optimize any underlying message with A/B testing.

As the largest professional social network and digital distribution platform for musicians and other creative types, Vampr has created numerous journeys since selecting Airship in August 2020. A recently launched reactivation journey targets app users who have been inactive for five days with a series of three push notifications and a final email within two weeks, and has been found to reactivate users at a 277 percent higher rate than those in the control group.

“My goal is to drive critical business KPIs by getting users to complete their profiles, connect with nearby creatives, add their original songs and videos, and much more — 90 percent of the time I’m using Airship Journeys to optimize these user experiences,” said Jessy Trengove, head of insights, Vampr. “By being able to easily see journey performance against baseline metrics and control groups, I’m more easily able to achieve the goals that make a real difference to the business.”

On Black Friday, J. C. Penney Company, Inc. used Airship Journeys to transform a one-message cart abandonment automation into a two-message journey and found significant lift in completed purchases. This cart abandonment journey now shows an all-time increase of 40 percent higher purchase completion rates over the control group baseline. JCP reactivation messages spread across three separate automations are now being combined into a single journey, enabling a goal-based view of business impact rather than trying to draw conclusions by comparing each message’s engagement metrics.

“With Airship Journeys, we can see where each customer comes into and progresses through each phase and can more easily A/B test any message in the journey to optimize timing, triggers, copy and content,” said Haley Welmon, owned media specialist, JCPenney. “Airship Journeys control groups and baselines help us make decisions and increase revenue more quickly, so we can maximize our success and ensure that what we think is the best experience for the customer, actually is.”

In hospitality, in their mobile app, Radisson Hotel Group has created a cart abandonment journey series spanning three messages over four days — the first of which guarantees the room’s rate — driving an 11 percent lift in completed reservations over the control group.

Tune in to the webinar, “Creating Extraordinary Customer Journeys with a Culture of Experimentation,” live Thursday, October 29 at 10am PDT / 1pm EDT / 5pm GMT / 6pm CET (recording available to registrants), and learn how to gain advantage by experimenting, testing and optimizing critical cross-channel customer journeys.

“It’s so gratifying to see how quickly brands have realized substantial business gains due to the powerful way we’ve reinvented cross-channel journeys for the mobile era,” said Brett Caine, CEO and president, Airship. “Engaging customers with in-the-moment relevancy across digital channels has never been more important, and small improvements can drive big results. Airship Journeys brings breakthrough simplicity to the entire process and speeds insights-to-optimization to accelerate revenue growth.”

Recently, Airship was named a Leader in “The Forrester Wave™: Mobile Engagement Automation, Q3 2020,” receiving the highest score in the Strategy category (tied) and the second highest score in the Current Offering category.

About Airship

Thousands of the world’s leading brands rely on Airship to spark closer connections with their customers through highly contextual and relevant interactions. Only Airship’s Customer Engagement Platform takes a mobile-first, data-led approach that enables brands to focus on individuals and their needs, not which marketing channels to use. Airship makes it much simpler and more effective to grow customer lifetime value in the omnichannel era.

With trillions of interactions intelligently orchestrated across mobile apps, mobile wallet, SMS, websites, and email, Airship optimizes the entire customer journey across all digital touchpoints at scale.

For more information, visit www.airship.com, read our blog or follow us on Twitter, LinkedIn and Facebook.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

North America:
Danielle Stickler
Mission North for Airship
+1 415-749-9124
airship@missionnorth.com

Corey Gault
Airship
+1 503-206-9164
corey@airship.com

UK:
Ana Williams
Airship
+44 (0)20 3405 5160
Ana.Williams@airship.com

France:
Samira Chakkaf Andalouci
Pepper Menthe Communication for Airship
07 86 11 14 52
Samira@peppermenthe.com

Germany:
Kerstin Bauer
Koschade PR
+49 89 55066850
info@koschadepr.de

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

FPT Named an OpenAI Select Partner6.8.2026 03:00:00 EEST | Press release

Global IT corporation FPT today announced that it has been named an OpenAI Select Partner within the OpenAI Partner Network. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260805503787/en/ FPT Named an OpenAI Select Partner The OpenAI Partner Network is a global program for partners to build, sell, and deliver AI solutions with OpenAI. It brings together partners with deep industry expertise, delivery capabilities, and customer relationships while equipping them with resources, enablement, and support to help enterprises adopt OpenAI frontier models and products and turn them into measurable impact. As an OpenAI Select Partner, FPT will continue working with OpenAI to help organizations build, deploy, and scale AI solutions responsibly and effectively. This work will help organizations get more useful work from every token and stronger performance per dollar with GPT‑5.6, while using ChatGPT Work to turn ambitious goals into

U.S. FDA Approves Takeda’s ORZEYFUL™ (oveporexton), the First and Only Medicine to Treat the Underlying Cause of Narcolepsy Type 16.8.2026 01:10:00 EEST | Press release

Takeda (TSE:4502/NYSE:TAK) announced that the U.S. Food and Drug Administration (FDA) approved ORZEYFUL™ (oveporexton), an oral orexin receptor 2 (OX2R) agonist, for the treatment of narcolepsy type 1 (NT1, narcolepsy with cataplexy) in adults.* The persistent 24-hour nature of NT1 is driven by orexin deficiency and can severely impact people’s lives. As a first-in-class orexin treatment, ORZEYFUL is the only medicine indicated in the U.S. to treat the disease holistically rather than individual symptoms. “The FDA approval of ORZEYFUL marks a new chapter for the narcolepsy type 1 community, as we introduce an entirely new class of medicine that will potentially redefine how this disease is managed and howpeople feel on treatment,” said Julie Kim, president and chief executive officer of Takeda. “We are proud to have discovered and developed this orexin treatment innovation and will bring it to adults living with NT1 as quickly as possible.” NT1 is a rare, chronic neurological disease d

Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)5.8.2026 23:30:00 EEST | Press release

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, announced today that Compass granted equity awards under the Compass Pathways plc 2026 Inducement Plan to fourteen newly hired non-executive employees. The equity awards were granted on August 3, 2026 and consisted of options to purchase an aggregate of 139,355 shares and restricted share units or, in the case of employees in the United Kingdom nominal cost options, covering an aggregate of 66,300 shares. The options have an exercise price per share equal to $11.25, the closing price of the Company’s American Depositary Shares on the Nasdaq Global Select Market on the grant date, and will vest over a four-year period with 25% vesting on the first anniversary of the date of the grant and the remaining 75% vesting in equal monthly installments over the three-year period thereafter, subject to each employee’s continued employment. The restricted

Clinilabs Announces Medical Leadership Appointments5.8.2026 17:05:00 EEST | Press release

Clinilabs (“Clinilabs LLC”), a global, full-service contract research organization (CRO) specializing in central nervous system (CNS) drug and device development, today announced the appointments of Bob Dagher, M.D., as Chief Medical Officer and Waqar Ahmed Siddiqui, M.D., as Principal Investigator of the Company’s Eatontown, New Jersey Clinical Research Unit (CRU). Dr. Dagher will provide strategic and medical leadership across the organization, while Dr. Siddiqui will lead the execution of research projects at the Company’s CRU. Together, they will support the design, development, and execution of clinical programs for pharmaceutical, biotechnology, and medical device sponsors advancing innovative therapies for psychiatric, neurological, substance use, and rare CNS disorders. “Clinilabs has earned the trust of sponsors by combining deep scientific expertise, medical leadership, and operational excellence with a track record of execution from first-in-human studies through regulatory

Interactive Brokers Adds Brazilian Futures through Brazil’s B3 Exchange5.8.2026 17:00:00 EEST | Press release

Interactive Brokers (Nasdaq: IBKR), an automated global broker, today announced that eligible clients outside of Brazil can now trade Brazilian futures in addition to equities through the B3 exchange. Interactive Brokers was the first broker to provide international investors with streamlined, low-cost access to B3. Offering Brazilian futures and equities alongside products across more than 170 markets worldwide underscores IBKR’s commitment to broadening global market access and giving clients efficient, cost-effective ways to diversify through a single, unified platform. Access to B3 provides exposure to one of Latin America’s most active and liquid markets, providing long-term growth potential across multiple sectors and another way for investors to pursue emerging market opportunities. "Global investors deserve seamless, low-cost access to the world's most compelling markets, including emerging economies shaping tomorrow's financial landscape," said Milan Galik, Chief Executive Off

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye